Luca Licata

Dr. Luca Licata is a physician-scientist specializing in breast cancer at IRCCS San Raffaele Hospital in Milan, affiliated with Vita-Salute San Raffaele University. He serves within the Oncology Medicine Unit and Oncology Day Hospital under Professor Stefano Cascinu's leadership, and is an active member of the Translational Clinical and Immunotherapeutic Research Group.

His educational background includes:

• MD in Medicine and Surgery from Vita-Salute San Raffaele University (2013)
• Specialization in Medical Oncology from University of Pavia (2019)

Dr. Licata's research centers on triple-negative breast cancer with dual clinical-translational focus. He investigates immunotherapy response biomarkers and resistance mechanisms while actively participating in clinical trials evaluating novel therapeutic approaches. His work bridges laboratory discoveries with patient care through the hospital's dedicated research infrastructure.

As an active contributor to oncology literature, he serves as peer reviewer for multiple high-impact journals including British Journal of Cancer and Breast Cancer Research and Treatment. His clinical practice exclusively treats women across all breast cancer stages while advancing therapeutic innovation through investigator-led studies.

He maintains strong institutional integration through the Translational Clinical and Immunotherapeutic Research Group, which drives immunotherapy advancements for solid tumors within the Department of Medical Oncology's framework.